Royal Bank Of Canada Ginkgo Bioworks Holdings, Inc. Transaction History

Royal Bank Of Canada

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $9,460 - $39,192	-33,787 Reduced 58.93%	23,545 $7,000
Q1 2024 Nov 05, 2024	BUY	$1.06 - $1.67 $35,814 - $56,424	33,787 Added 143.5%	57,332 $66,000
Q1 2024 May 15, 2024	SELL	$1.06 - $1.67 $10,176 - $16,032	-9,600 Reduced 14.34%	57,332 $66,000
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $2,716 - $3,859	2,156 Added 3.33%	66,932 $113,000
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $37,488 - $59,143	23,285 Added 56.12%	64,776 $117,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $22,494 - $38,477	19,732 Added 90.68%	41,491 $77,000
Q1 2023 May 15, 2023	SELL	$1.2 - $2.19 $18,522 - $33,802	-15,435 Reduced 41.5%	21,759 $28,000
Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $24,764 - $53,479	-15,193 Reduced 29.0%	37,194 $62,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $17,248 - $88,368	23,628 Added 82.16%	52,387 $163,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $24,926 - $47,586	11,330 Added 65.01%	28,759 $69,000
Q1 2022 May 16, 2022	BUY	$2.83 - $8.69 $4,420 - $13,573	1,562 Added 9.84%	17,429 $70,000
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $86,191 - $154,750	10,372 Added 188.75%	15,867 $133,000
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $50,279 - $72,973	5,495 New	5,495 $63,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.